2009-2011 Test Discontinuation Memoranda

July 1, 2011
  • 4512 – Fucosidase Enzyme Analysis – White Blood Cells (WBC)
  • 4513 – Fucosidase Enzyme Analysis – Skin Fibroblast Culture (SFC)
  • 4520 – Alpha-Glucosidase Enzyme Analysis – Skin Fibroblast Culture (SFC)
  • 4519 – Alpha-Glucosidase Enzyme Analysis – Muscle
  • 4518 – Not currently on website
  • 4528 – Mannosidase Enzyme Analysis – White Blood Cells (WBC)
  • 4527 – Mannosidase Enzyme Analysis – Skin Fibroblast Culture (SFC)
  • 4540 – Arylsulfatase B Enzyme Analysis – Skin Fibroblast Culture (SFC)
  • 4550 – Beta-Glucuronidase Enzyme Assay – Serum
  • 4551 – Beta-Glucuronidase Enzyme Assay – Skin Fibroblast
  • 4579 – Alpha-N-Acetylglucosaminidase Enzyme Analysis – Plasma/Serum
  • 4580 – Alpha-N-Acetylglucosaminidase Enzyme Analysis – Skin Fibroblast Culture (SFC)
  • 4618 – Not currently on website
  • 6003 – Ashkenazic Genetic Disease Panel with Hexosaminidase A & B
March 1, 2011
  • 3026 – Leber Hereditary Optic Neuropathy (LHON) Mutation Panel (Targeted Analysis)
December 1, 2010
  • 4619 – Galactosemia Enzyme Analysis
August 1, 2010
  • 6094 – MLH1, MLH2, & MSH6 Sequencing Panel discontinued and replaced with 6725 – HNPCC Comprehensive Panel
July 1, 2010
  • 8475 – PLP1-Related Disorders FISH Analysis
  • 6052 – RhD Genotyping
  • 6111 – RhD Genotyping Prenatal
December 1, 2009
  • 4619 – Galactosemia Enzyme Analysis
August 1, 2009
  • 4540 – Maroteaux Lamy Disease (MPS VI), Arylsulfatase B Enzyme Analysis
Next Post
Test Change Memorandum – Cystic Fibrosis
Menu